CTKB Cytek Biosciences, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Cytek Biosciences, Inc. (CTKB) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on August 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Cytek Biosciences, Inc. (CTKB) (SEC CIK 1831915), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Cytek Biosciences, Inc.
Ask AI about CTKB filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting CTKB positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on CTKB.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Cytek Biosciences, Inc. (CTKB) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 5, 2026 | - | - | - |
8-K | Jul 15, 2026 | - | - | - |
8-K | Jun 25, 2026 | - | - | - |
8-K | Jun 16, 2026 | - | - | - |
8-K | Jun 2, 2026 | - | - | |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
8-K | May 7, 2026 | - | - | |
8-K | Feb 26, 2026 | - | Analysis | - |
10-K | Feb 26, 2026 | Dec 31, 2025 | - | |
8-K | Jan 13, 2026 | - | - | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 6, 2025 | Jun 30, 2025 | - | |
10-Q | May 8, 2025 | Mar 31, 2025 | - | |
10-K | Feb 28, 2025 | Dec 31, 2024 | - | |
SC 13G | Nov 14, 2024 | - | - | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 6, 2024 | Jun 30, 2024 | - | |
10-Q | May 8, 2024 | Mar 31, 2024 | - | |
10-K | Mar 13, 2024 | Dec 31, 2023 | - | |
SC 13G | Feb 22, 2024 | - | - | |
SC 13G | Feb 14, 2024 | - | - | |
10-Q | Nov 14, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | - | |
10-Q | May 9, 2023 | Mar 31, 2023 | - | |
10-K | Mar 1, 2023 | Dec 31, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate CTKB share value held by 13F filers tracked by SignalX, by quarter.
- Millennium Management+1.54M (+32%)
- Goldman Sachs Group+554.8K (+31%)
- Citadel Advisors LLC+316.1K (+190%)
- AQR Capital Management+168.9K (+23%)
- Bank of America Corp+152.9K (+18%)
- BlackRock165.8K (-1%)
- Principal Financial Group132.2K (-20%)
- Wells Fargo & Co87.4K (-66%)
- M&T Bank32.3K (-76%)
- BNY Mellon29.3K (-5%)
- Franklin Resources+114.0K
- Vanguard Group Inc−7.48M
- Invesco Ltd−398.8K
- JPMorgan Chase & Co−328.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 180 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest CTKB SEC filings in 2026?
Cytek Biosciences, Inc. (CTKB) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CTKB file its most recent 10-K annual report?
Cytek Biosciences, Inc. (CTKB) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CTKB 10-Q quarterly reports?
Cytek Biosciences, Inc. (CTKB)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every CTKB 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CTKB filed recently?
Cytek Biosciences, Inc. (CTKB)'s most recent 8-K was filed on August 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CTKB insider trading activity (Form 4)?
SignalX aggregates every CTKB Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CTKB file with the SEC?
Cytek Biosciences, Inc. (CTKB) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CTKB filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Cytek Biosciences, Inc. (CTKB).
What is CTKB's SEC CIK number?
Cytek Biosciences, Inc. (CTKB)'s SEC CIK (Central Index Key) number is 1831915. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1831915 to look up all CTKB filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Cytek Biosciences, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 38+ filings.